IGC Pharma, Inc. financial data

Symbol
IGC on NYSE
Industry
Pharmaceutical Preparations
Location
10224 Falls Road, Potomac, MD
State of incorporation
Maryland
Fiscal year end
March 31
Former names
India Globalization Capital, Inc. (to 3/21/2023)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 201 % -57.7%
Quick Ratio 85.8 % -54.6%
Debt-to-equity 25.8 % +107%
Return On Assets -110 % -91.2%
Operating Margin -947 % -8.85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 75.6M shares +42.5%
Common Stock, Shares, Outstanding 75.6M shares +42.5%
Entity Public Float 20.9M USD +0.34%
Weighted Average Number of Shares Outstanding, Basic 72.8M shares +37.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.06M USD -15.3%
Cost of Revenue 421K USD -39.8%
Research and Development Expense 3.92M USD +39.1%
Operating Income (Loss) -10.1M USD +7.82%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.3M USD -23.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -13.3M USD -23.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.82M USD +5.86%
Marketable Securities, Current 154K USD
Accounts Receivable, after Allowance for Credit Loss, Current 28K USD -87.6%
Inventory, Net 1.51M USD -42.8%
Other Assets, Current 240K USD +24.4%
Assets, Current 4.41M USD -13.2%
Other Long-term Investments 0 USD -100%
Property, Plant and Equipment, Net 3.59M USD -55.8%
Operating Lease, Right-of-Use Asset 193K USD -34.6%
Intangible Assets, Net (Excluding Goodwill) 1.72M USD +45.9%
Other Assets, Noncurrent 688K USD -32.4%
Assets 10.6M USD -32.4%
Accounts Payable, Current 771K USD +14.7%
Employee-related Liabilities, Current 1.01M USD +34.8%
Accrued Liabilities, Current 1.72M USD +17.8%
Liabilities, Current 2.49M USD +16.8%
Operating Lease, Liability, Noncurrent 69K USD -61.5%
Other Liabilities, Noncurrent 20K USD -4.76%
Liabilities 2.71M USD +9.83%
Common Stocks, Including Additional Paid in Capital 127M USD +6.73%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.43M USD -1.36%
Retained Earnings (Accumulated Deficit) -116M USD -12.9%
Stockholders' Equity Attributable to Parent 7.88M USD -40.3%
Liabilities and Equity 10.6M USD -32.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.75M USD -19.3%
Net Cash Provided by (Used in) Financing Activities 2.51M USD
Net Cash Provided by (Used in) Investing Activities -131K USD -2520%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 75.6M shares +42.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 626K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.82M USD +5.86%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 15M USD +10.3%
Deferred Tax Assets, Gross 15M USD +10.3%
Operating Lease, Liability 208K USD -38.8%
Depreciation 568K USD +41.3%
Payments to Acquire Property, Plant, and Equipment 38K USD +90%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.3M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid 340K USD -26.7%
Property, Plant and Equipment, Gross 6.17M USD -39.4%
Operating Lease, Liability, Current 133K USD +3.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 87K USD -34.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 132K USD -12.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD -64.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 26K USD -3.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 76K USD +16.9%
Depreciation, Depletion and Amortization 162K USD +4.52%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 402K USD +12.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%